BRG
IDXX icon

Bay Rivers Group’s Idexx Laboratories IDXX Stock Holding History

Bay Rivers Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-628
Closed -$275K – 72
2023
Q3 		$275K Sell
628
-14
-2% -$6.98K 0.21% 58
2023
Q2 		$322K Hold
642
– – 0.24% 56
2023
Q1 		$321K Sell
642
-7
-1% -$3.35K 0.28% 49
2022
Q4 		$265K Hold
649
– – 0.27% 53
2022
Q3 		$211K Hold
649
– – 0.21% 56
2022
Q2 		$228K Sell
649
-43
-6% -$17.5K 0.2% 56
2022
Q1 		$379K Sell
692
-14
-2% -$7.36K 0.27% 61
2021
Q4 		$465K Buy
706
+221
+46% +$139K 0.28% 64
2021
Q3 		$302K Buy
485
+113
+30% +$75.9K 0.21% 71
2021
Q2 		$235K Buy
+372
New +$205K 0.17% 66

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Bay Rivers Group's IDXX Position: Q4 2023 in Review

Bay Rivers Group sold out of Idexx Laboratories (IDXX) in Q4 2023, closing a stake of 628 shares — an estimated $275K sold.

Bay Rivers Group first reported a position in IDXX in Q2 2021 and held it in 10 quarters. The position peaked at $465K in Q4 2021. 1,154 funds tracked by Wall St. Rank hold IDXX as of Q4 2023.

  • Bay Rivers Group reported no remaining Idexx Laboratories position as of Q4 2023 after selling out during the quarter.
  • Bay Rivers Group sold 628 Idexx Laboratories shares in Q4 2023, an estimated $275K.
  • Bay Rivers Group first reported a position in Idexx Laboratories in Q2 2021 and held it in 10 quarters.
  • Bay Rivers Group's Idexx Laboratories position peaked at $465K in Q4 2021.
  • 1,154 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2023.

Based on Bay Rivers Group's 13F filing for Q4 2023, filed 12 Jan 2024.